• Dr. Md. Maniruzzaman

Coronavirus disease-19 (COVID-19) is a global pandemic caused by the “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2), which was isolated for the first time in Wuhan (China) in December 2019. Common symptoms include fever, cough, fatigue, dyspnea and hypogeusia/hyposmia. Among extrapulmonary signs associated with COVID-19, dermatological manifestations have been increasingly reported in the last few months. The polymorphic nature of COVID-19-associated cutaneous manifestations led our group to propose a classification, which distinguishes the following six main clinical patterns: (i) urticarial rash, (ii) confluent erythematous/ maculopapular/ morbilliform rash, (iii) papulovesicular exanthem, (iv) chilblain- like acral pattern, (v) livedo reticularis/racemosa-like pattern, (vi) purpuric “vasculitic” pattern. This review summarizes the current knowledge on COVID-19-associated cutaneous manifestations, focusing on clinical features and therapeutic management of each category and attempting to give an overview of the hypothesized pathophysiological mechanisms of these conditions.

Dermatological Presentation, Coronavirus disease-19, Urticarial Eruptions, Pathophysiology, Prevalence

"Dermatological Presentation of Covid-19 Positive and Post Covid-19 Patients", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 8, page no.f56-f70, August-2023, Available :http://www.jetir.org/papers/JETIR2308510.pdf

"Dermatological Presentation of Covid-19 Positive and Post Covid-19 Patients", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 8, page no. ppf56-f70, August-2023, Available at : http://www.jetir.org/papers/JETIR2308510.pdf